echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimers Dementia: What are the characteristics of brain metabolism in patients with delirium?

    Alzheimers Dementia: What are the characteristics of brain metabolism in patients with delirium?

    • Last Update: 2022-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Delirium affects up to 40% of hospitalized patients over the age of 65 and is associated with a 3-fold increased chance of death, but the neural mechanisms responsible for delirium remain unknown
    .


    Delirium and dementia are distinct but interrelated causes of cognitive impairment



    Due to the epidemiological and clinical overlap of delirium and dementia, it is of clinical interest to study their common pathophysiological mechanisms
    .


    However, histopathological studies suggest that cognitive decline following delirium is caused by mechanistically distinct pathways other than those classically associated with dementia, such as amyloid plaques, neurofibrillary tangles, and vascular damage



    diagnosis

    Decreased brain glucose metabolism, and as a biomarker, plays an important role in the pathophysiology of AD
    .


    Clinical trials targeting bioenergetic pathways in the human brain have shown some promising early results


    Inadequate brain metabolism is also a feature of delirium
    .


    Cerebrospinal fluid (CSF) in elderly patients with delirium has increased levels of lactate and altered levels of key carbohydrate enzymes, suggesting suppressed aerobic metabolism


    Two studies using FDG-PET to assess glucose metabolism during delirium found cortical hypometabolism
    .


    However, dementia and acute illness may have been important confounders in both studies


    In this exploratory study, Anita Nitchingham and others at the University of New South Wales, Australia, sought to determine whether any part of the brain that is low in glucose metabolism is primarily attributable to delirium rather than acute disease or dementia
    .


    They used FDG-PET to compare distressed patients with delirium but no dementia diagnosis or symptoms to an acutely distressed control group without delirium but also without dementia


    They used 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) to assess brain glucose metabolism in elderly patients with and without delirium, all without clinical dementia (N = 20)
    .


    Strict exclusion criteria were adopted to minimize the effect of established confounders on FDG-PET


    They found that patients with delirium showed hypometabolism in the bilateral thalamus and right upper frontal, right posterior cingulate, right medial-lateral anterior temporal, and left superior parietal cortex
    .

    Regional hypometabolism was associated with delirium severity and performance on neuropsychological tests
    .

    The significance of the study lies in the finding that in patients with acute disease but no clinical dementia, delirium is accompanied by regional cerebral hypometabolism
    .


    While some areas of hypometabolism may represent preclinical Alzheimer's disease (AD), hypometabolism in the thalamus is atypical of AD, consistent with clinical features specific to delirium
    .

    Delirium is associated with regional cerebral hypometabolism in patients with acute illness but no clinical dementia


    Original source:


    Nitchingham A, Pereira JV, Wegner EA, Oxenham V, Close J, Caplan GA.
    Regional cerebral hypometabolism on 18F-FDG PET/CT scan in delirium is independent of acute illness and dementia .
    Alzheimer's & Dementia.
    Published online March 15, 2022: alz.
    12604.
    doi:10.
    1002/alz.
    12604

    Regional cerebral hypometabolism on 18F-FDG PET/CT scan in delirium is independent of acute illness and dementia
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.